These findings suggested that cardiomyocyte-specific knockdown of SLC40A1 impedes the iron loss in ischemic cardiomyocytes, consequently reducing the infarct size and enhancing cardiac function after MI. Here, SLC40A1 is linked to myocardial infarction.